US Stem Cell (USRM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2016 | 06-2016 | 03-2016 | 12-2015 | 09-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,397 | -716 | -363 | -1,642 | -283 |
| Depreciation Amortization | 4 | 2 | 1 | 5 | 4 |
| Accounts receivable | -20 | -23 | -36 | 22 | 2 |
| Accounts payable and accrued liabilities | 79 | 14 | -63 | 435 | 324 |
| Other Working Capital | 1,043 | 88 | -68 | 868 | 630 |
| Other Operating Activity | 1,178 | 469 | 466 | -532 | -1,466 |
| Operating Cash Flow | $-113 | $-166 | $-62 | $-845 | $-790 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -12 | 1 | 1 | -2 | -1 |
| Purchase Of Investment | 115 | 65 | 50 | -10 | -10 |
| Other Investing Activity | 0 | 0 | -8 | -222 | -158 |
| Investing Cash Flow | $103 | $66 | $43 | $-234 | $-169 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 15 | 15 | 373 | 784 | 548 |
| Debt Issued | 523 | 458 | N/A | N/A | N/A |
| Debt Repayment | -103 | -82 | -66 | N/A | N/A |
| Common Stock Issued | 0 | 0 | N/A | 583 | 583 |
| Common Stock Repurchased | -8 | -8 | N/A | N/A | N/A |
| Other Financing Activity | -229 | -211 | -71 | -266 | -144 |
| Financing Cash Flow | $198 | $173 | $236 | $1,100 | $987 |
| Beginning Cash Position | 58 | 58 | 58 | 37 | 37 |
| End Cash Position | 246 | 131 | 275 | 58 | 66 |
| Net Cash Flow | $188 | $73 | $217 | $22 | $29 |
| Free Cash Flow | |||||
| Operating Cash Flow | -113 | -166 | -62 | -845 | -790 |
| Capital Expenditure | -13 | N/A | N/A | -2 | -1 |
| Free Cash Flow | -126 | -166 | -62 | -847 | -790 |